Real-time enrollment status for this urothelial carcinoma bladder clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:02 PM UTC
| NCT Number | NCT07020117 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Carcinoma Bladder |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Aktis Oncology, Inc. |
| Last Updated on CT.gov | September 17, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07020117 is currently recruiting participants. This phase1 study for urothelial carcinoma bladder is actively seeking new participants at 14 locations across the United States. The study is sponsored by Aktis Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07020117 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07020117 was last updated 3 weeks ago (September 17, 2026). HelloStudys verifies this status automatically.